Trials / Completed
CompletedNCT03323450
Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Virginia Commonwealth University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate a computer-based Cognitive Remediation Therapy (CRT) for brain tumor patients at the Massey Cancer Center on measures of cognitive functioning (e.g., working memory, attention, processing speed, language, visuospatial functioning, immediate and delayed memory, or executive functioning) over time.
Detailed description
Participants will be recruited by their neuropsychologist in the VCU Massey Cancer Center following standard neuropsychological evaluation (their neuro-oncologist may refer them to this study). If meeting inclusion criteria (described in later sections on participants), participants will be recruited and enrolled in the study. Two groups will be formed: High grade gliomas (WHO grade III or IV; n=15) and Low grade gliomas (WHO grade II; n=15). Participants will be followed over 11 months. The two groups will follow identical study timelines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | CogMed® | It consists of 25 training sessions which can all be completed online and at home. Each session lasts 30-45 minutes. They must have a computer at home compatible with the CogMed® program. Brief neuropsychological evaluations will be conducted at 4 time points (these assessments are standard of care): 1. Baseline before the participant is introduced to the CogMed® training program 2. Within 2 weeks of completion of the CogMed® program 3. At 3 months of completion of the CogMed® program to establish maintenance of gains 4. At 6 months of completion of the CogMed® program to establish longer-term maintenance of gains |
Timeline
- Start date
- 2017-10-20
- Primary completion
- 2020-06-01
- Completion
- 2020-06-01
- First posted
- 2017-10-27
- Last updated
- 2020-10-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03323450. Inclusion in this directory is not an endorsement.